锦波生物
(920982)
| 流通市值：131.66亿 | | | 总市值：275.93亿 |
| 流通股本：5490.51万 | | | 总股本：1.15亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,295,732,666.6 | 858,703,187.63 | 366,465,963.91 | 1,442,831,399.69 |
| 营业收入 | 1,295,732,666.6 | 858,703,187.63 | 366,465,963.91 | 1,442,831,399.69 |
| 二、营业总成本 | 620,389,060.82 | 392,263,236 | 170,803,059.27 | 593,759,725.34 |
| 营业成本 | 119,180,681.79 | 80,059,525.05 | 36,235,023.96 | 115,199,689.85 |
| 税金及附加 | 21,376,768.42 | 12,742,937.39 | 4,747,580.76 | 11,100,457.51 |
| 销售费用 | 289,442,165.63 | 180,787,544.42 | 78,181,602.67 | 258,541,974.84 |
| 管理费用 | 112,971,706.25 | 68,496,261.12 | 30,267,601.7 | 127,369,723.95 |
| 研发费用 | 71,261,580.37 | 45,796,192.02 | 19,030,382.1 | 71,213,218.83 |
| 财务费用 | 6,156,158.36 | 4,380,776 | 2,340,868.08 | 10,334,660.36 |
| 其中:利息费用 | 5,680,008.72 | 3,996,344.32 | 2,255,310.11 | 10,490,652.66 |
| 其中:利息收入 | 622,359.06 | 393,048.81 | 211,678.96 | 1,034,367.19 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 4,889,164.88 | 2,885,501.07 | 1,024,969.32 | 1,277,383.57 |
| 资产减值损失(新) | -11,561,283.52 | -10,822,324.14 | -2,102,097.17 | -13,872,526.14 |
| 信用减值损失(新) | -7,805,119.56 | -3,693,179.11 | 1,435,755.74 | -4,131,325.07 |
| 其他收益 | 10,182,080.7 | 7,605,759.58 | 2,991,854.02 | 21,965,364.57 |
| 四、营业利润 | 671,048,448.28 | 462,415,709.03 | 199,013,386.55 | 854,310,571.28 |
| 加:营业外收入 | 111,490.62 | 33,304.61 | 322.99 | 6,049,105.43 |
| 减:营业外支出 | 4,463,477.39 | 4,194,620.02 | 1,791,339.48 | 2,908,927.02 |
| 五、利润总额 | 666,696,461.51 | 458,254,393.62 | 197,222,370.06 | 857,450,749.69 |
| 减:所得税费用 | 102,056,444.36 | 67,543,224.26 | 29,041,423.68 | 126,276,216.02 |
| 六、净利润 | 564,640,017.15 | 390,711,169.36 | 168,180,946.38 | 731,174,533.67 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 564,640,017.15 | 390,711,169.36 | 168,180,946.38 | 731,174,533.67 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 568,273,346.52 | 392,057,939.84 | 168,530,398.04 | 732,301,620.38 |
| 少数股东损益 | -3,633,329.37 | -1,346,770.48 | -349,451.66 | -1,127,086.71 |
| 扣除非经常损益后的净利润 | 559,736,614.17 | 387,262,463.17 | 167,143,239.69 | 712,180,480.92 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 4.94 | 3.41 | 1.9 | 8.27 |
| (二)稀释每股收益 | 4.94 | 3.41 | 1.9 | 8.27 |
| 九、综合收益总额 | 564,640,017.15 | 390,711,169.36 | 168,180,946.38 | 731,174,533.67 |
| 归属于母公司股东的综合收益总额 | 568,273,346.52 | 392,057,939.84 | 168,530,398.04 | 732,301,620.38 |
| 归属于少数股东的综合收益总额 | -3,633,329.37 | -1,346,770.48 | -349,451.66 | -1,127,086.71 |
| 公告日期 | 2025-10-29 | 2025-08-11 | 2025-04-22 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |